
Edelweiss Nifty 100 Quality 30 Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Updated: 17 Sept 2026 • 12:06 pm
Posted by:

Edelweiss Nifty 100 Quality 30 Index Fund Direct Growth Plan is priced at ₹14.2863 as of 16 Sep 2026, with scheme AUM of ₹118 Cr. Its 1-year, 3-year and 5-year returns are -4.82%, 7.39% and 0% respectively, and the scheme sits in the High Risk bucket. Our view is that this is a portfolio-led index strategy for investors who can tolerate interim weakness and want a rules-based quality screen, but the recent drawdown means it has not been a smooth holding over the latest year.
It may suit a longer horizon better than a short one, especially because the 3-year figure is positive while the latest 1-year outcome remains negative. The fund is also running with a relatively tight portfolio of 30 holdings, which can sharpen the impact of its largest positions.
Quick facts
| Particular | Details |
|---|---|
| NAV | ₹14.2863 as of 16 Sep 2026 |
| AUM | ₹118 Cr |
| Expense Ratio | 0.32% |
| Launch Date | 07 Oct 2021 |
| Min SIP | ₹100 |
| Risk Category | High Risk |
| Benchmark | Nifty 50 |
| Fund Category | Index Funds |
| Exit Load | No exit load |
| Fund Managers | Bhavesh Jain, Bharat Lahoti, Manasi Jalgaonkar |
The fund is managed by Bhavesh Jain, Bharat Lahoti and Manasi Jalgaonkar.
Source data date: as of 16 Sep 2026
Performance
| Period | Fund return | Benchmark return |
|---|---|---|
| 1M | -5.25% | -4.41% |
| 3M | -1.35% | -3.60% |
| 1Y | -4.82% | -7.76% |
| 3Y | 7.39% | 5.74% |
| 5Y | Data not available | Data not available |
Recent performance has been weak, and the latest 1-month and 3-month figures show that the fund has continued to move through short-term pressure. The 1-month return of -5.25% is worse than the benchmark’s -4.41%, while the 3-month return of -1.35% is better than the benchmark’s -3.60%, so the short-term picture is mixed rather than one-sided.
The bigger point is that the 1-year return remains negative at -4.82%, but it still beats the benchmark’s -7.76%. That tells us the fund has lost value over the past year, yet it has held up better than the benchmark in that same window. This is useful context for a passive strategy: even when it lags in the near term, it can still behave differently from the broad market reference.
Over 3 years, the fund has returned 7.39% against 5.74% for the benchmark. That is a firmer signal than the recent numbers, because it suggests the fund’s longer compounding has been more resilient than its latest year implies. The daily pattern also points to a choppy path rather than a straight trend, so investors should expect uneven stretches even when the longer horizon improves.
Source data date: as of 16 Sep 2026
Should you BUY or HOLD Edelweiss Nifty 100 Quality 30 Index?
A fund's past returns alone don't tell you whether you should buy it today or continue holding it.
The right decision depends on factors such as your current allocation, purchase price, risk profile, investment horizon and the role this fund plays in your overall portfolio.
Already holding Edelweiss Nifty 100 Quality 30 Index? Thinking of investing now?
Peer comparison
| Fund | 1Y return | 3Y return | 5Y return |
|---|---|---|---|
| Edelweiss Nifty 100 Quality 30 Index Fund Direct Growth Plan | -4.82% | 7.39% | Data not available |
| ICICI Pru NASDAQ 100 Index Fund Direct Growth Plan | 29.31% | 30.01% | Data not available |
| Tata Nifty Capital Markets Index Fund Direct Growth Plan | 21.45% | Data not available | Data not available |
| Motilal Oswal Nifty Capital Market Index Fund Direct Growth Plan | 21.13% | Data not available | Data not available |
| Motilal Oswal Nifty MidSmall Financial Services Index Fund Direct Growth Plan | 20.68% | Data not available | Data not available |
| ICICI Pru Nifty Pharma Index Fund Direct Growth Plan | 17.57% | 18.84% | Data not available |
This assessment is prepared by Uniapps Investment Adviser Pvt. Ltd. under SEBI Registered Investment Adviser registration INA000017639.
The fund’s recent return trails the strongest peer figures by a wide margin, especially on the 1-year view where several peers show strong double-digit gains. At the same time, the fund’s 3-year return is more constructive than its short-term performance suggests, and it is ahead of the benchmark’s 3-year return even though the latest year has been negative.
The longer view is more balanced: among peers with a 3-year figure, the fund is ahead of the ICICI Pru Nifty Pharma Index Fund and behind ICICI Pru NASDAQ 100 Index Fund. The short-term and longer-term comparisons therefore tell different stories, which is common when a fund has gone through a weaker recent stretch but still preserved a reasonable multi-year outcome.
Source data date: as of 16 Sep 2026
Want to know more? Log in to Univest for more mutual fund insights.
Portfolio: where your money goes
| Holding | Sector | Weight |
|---|---|---|
| Tata Consultancy Services Ltd. | IT | 5.41% |
| Nestle India Ltd. | FMCG | 5.14% |
| Infosys Ltd. | IT | 5.10% |
| Bharat Electronics Ltd. | Capital Goods | 4.74% |
| HCL Technologies Ltd. | IT | 4.54% |
| Bajaj Auto Ltd. | Automobile & Ancillaries | 4.50% |
| Hindustan Unilever Ltd. | FMCG | 4.26% |
| Maruti Suzuki India Ltd. | Automobile & Ancillaries | 4.26% |
| ITC Ltd. | FMCG | 4.18% |
| Britannia Industries Ltd. | FMCG | 4.01% |
The largest holding is Tata Consultancy Services Ltd. at 5.41%, so no single name dominates the portfolio on its own. Even so, the top 10 positions all sit in a fairly narrow band, with the tenth holding still above 4%, which suggests the fund is not relying on one or two oversized bets to drive its outcome.
The drop from the first holding to the tenth is modest rather than steep. That kind of profile may make the portfolio’s return pattern more dependent on how a cluster of large positions behaves together, particularly because IT, FMCG and automobile names appear repeatedly across the top list.
The top 10 holdings account for approximately 46.14% of the portfolio, and the fund has 30 disclosed holdings in total. That points to a noticeable concentration in the leading positions, but the remainder of the portfolio still leaves room for a broader tail of smaller weights. To see all holdings, visit the Edelweiss Nifty 100 Quality 30 Index Fund Direct Growth Plan page
Source data date: as of 16 Sep 2026
Who should invest
This fund fits investors who are comfortable with High Risk exposure and can hold through uneven periods. The latest year has been weak, but the 3-year result is positive and better than the benchmark over the same horizon, which makes the fund more suitable for a patient investor than for someone focused on near-term stability.
The main trade-off is that a quality-screened index approach can still go through sharp short-term swings, as the recent 1M and 3M numbers show. Investors with a longer horizon and tolerance for concentration in a limited set of large holdings may find the structure acceptable, while very cautious investors may prefer a smoother path.
Tax and exit load
| Holding period | Tax rate | Description |
|---|---|---|
| Units held less than 1 year | 20% | Short-term capital gains tax |
| Units held more than 1 year | 12.5% | Long-term capital gains tax |
Exit load: No exit load.
Source data date: as of 16 Sep 2026
Frequently asked questions
What is the current NAV of Edelweiss Nifty 100 Quality 30 Index Fund Direct Growth Plan?
It is ₹14.2863 as of 16 Sep 2026.
What are the fund’s 1-year, 3-year and 5-year returns?
The fund’s returns are -4.82% for 1 year, 7.39% for 3 years and 0% for 5 years.
How has the fund done versus its benchmark?
It has beaten the benchmark over 1 year and 3 years, but both have been negative over the latest 1-year window and the short-term path has been uneven.
Who manages the fund?
Bhavesh Jain, Bharat Lahoti and Manasi Jalgaonkar manage the fund.
What is the minimum SIP amount?
The minimum SIP is ₹100.
What is the exit load and risk category?
There is no exit load, and the scheme is in the High Risk category.
Bottom line
This fund’s recent weakness is clear in the latest 1-year and 1-month figures, but the 3-year outcome is still positive and ahead of the benchmark. That split tells us the fund has had a choppier near-term path than its longer view would suggest. Compared with peers, the short-term returns are well behind the strongest numbers, while the longer view is more respectable. The portfolio is concentrated enough for the largest holdings to matter, so it may fit investors who can stay invested through volatility and want a quality-screened index exposure.
Published on 17 September 2026 at 12:04 PM IST
Explore mutual funds with Univest
Review mutual fund data, compare performance and explore fund insights on Univest.
RIA disclosure
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully before investing. This review is prepared by Uniapps Investment Adviser Pvt. Ltd. (earlier known as Uniapps Global Research Pvt. Ltd.) under SEBI Registered Investment Adviser registration INA000017639 for general informational purposes and is not personalized investment advice.
Recent Articles

Groww Nifty Midcap 150 Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
17 September 2026

HDFC NIFTY Next 50 Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
17 September 2026

Samco Small Cap Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
17 September 2026

Axis Income Plus Arbitrage Passive FOF Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
17 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Groww Nifty Midcap 150 Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
HDFC NIFTY Next 50 Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Samco Small Cap Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Axis Income Plus Arbitrage Passive FOF Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
ITI Pharma & Healthcare Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Popular this week
Kotak Gold Silver Passive FOF Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





